HealthQuill Vaccines
Emergent BioSolutions Inc., got the US drug regulator’s approval to expand its smallpox vaccine use to treat mpox, according to a company statement.
Drugs Health Pharma

Emergent gets US drug regulator’s nod to use its smallpox vaccine for mpox

Emergent BioSolutions Inc., got the US drug regulator’s approval to expand its smallpox vaccine use to treat mpox, according to a company statement.

Read More
The SARS-CoV-2 virus was detected in six backyard species in the southeastern US state of Virginia with unique viral mutations with lineages closely matching variants circulating in humans, according to a study.
Drugs Health Pharma

Backyard species in US gets Covid-19 through human-to-animal spread

The SARS-CoV-2 virus was detected in six backyard species in the southeastern US state of Virginia with unique viral mutations with lineages closely.

Read More
Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative unveiled in October last year, when sales of its Covid-19 vaccine plummeted.
Drugs Health Pharma

Pfizer Inc. unveils a new $1.5 billion plan to cut costs as vaccine sales fall

Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative.

Read More
Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda Gates Foundation to fund its production of needle-free vaccines.
Health Medical Pharma

Micron gets $23.6m Gates Foundation grant to make needle-free vaccines

HQ Team November 20, 2023: Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda.

Read More
Pfizer plans to raise long-term debt worth $31 billion to finance its acquisition of Seagen, according to a company statement.
Drugs Health Medical Pharma

Pfizer to raise $31 billion in long-term debt for Seagen acquisition

HQ Team May 18, 2023: Pfizer plans to raise long-term debt worth $31 billion to finance its acquisition of Seagen, according to a.

Read More
Novavax, a COVID-19 vaccine maker, will lay off a quarter of its workforce and announced a global restructuring and cost reduction initiative as the sales of its vaccines fell amid a worldwide decline in the spread of the disease.
Drugs Medical Pharma

Novavax reports first-quarter loss, to lay off 25% of workforce

HQ Team May 10, 2023: Novavax, a COVID-19 vaccine maker, will lay off a quarter of its workforce and announced a global restructuring.

Read More
A nasal spray developed by Finnish researchers can prevent COVID-19 disease caused by all known variants and stop the transmission of the virus, according to a statement.
Drugs Pharma

Finnish researchers say new COVID-19 nasal spray hold future promise

A nasal spray developed by Finnish researchers can prevent COVID-19 disease caused by all known variants and stop the transmission of the virus, according to.

Read More
A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged governments to increase surveillance.
Climate Drugs Pharma

H5N1 influenza’s spread to mammals needs ‘close monitoring’

A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged.

Read More
COVID-19 will remain a pandemic as it continues to constitute a public health emergency of international concern, the WHO’s highest form of an alert.
Drugs Medical Pharma

COVID-19 to continue as public health emergency of international concern

COVID-19 will remain a pandemic as it continues to constitute a public health emergency of international concern, the WHO’s highest form of an.

Read More
depression
Drugs Health Pharma

Fentanyl vaccine breakthrough maybe a gamechanger for opioid epidemic

Scientists have developed a vaccine against fentanyl addiction that works in rats and is ready for human trials

Read More